![52 North Health](https://parkwalkadvisors.com/wp-content/uploads/2022/02/52-North-Health-website-image-1.png)
52 North is developing the world’s first finger-prick blood test to provide both a white blood cell count and blood lactate level, enabling rapid triage of chemotherapy patients at risk of life-threatening infections. 52 North is a spin-out from the University of Cambridge.